176 related articles for article (PubMed ID: 20093322)
1. Differential effect of glucocorticoid receptor antagonists on glucocorticoid receptor nuclear translocation and DNA binding.
Spiga F; Knight DM; Droste SK; Conway-Campbell B; Kershaw Y; MacSweeney CP; Thomson FJ; Craighead M; Peeters BW; Lightman SL
J Psychopharmacol; 2011 Feb; 25(2):211-21. PubMed ID: 20093322
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of the new glucocorticoid receptor antagonist ORG 34517 and RU486 (mifepristone) on glucocorticoid receptor nuclear translocation in the AtT20 cell line.
Peeters BW; Ruigt GS; Craighead M; Kitchener P
Ann N Y Acad Sci; 2008 Dec; 1148():536-41. PubMed ID: 19120154
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of RU28318 and RU40555 as selective mineralocorticoid receptor and glucocorticoid receptor antagonists, respectively: receptor measures and functional studies.
Kim PJ; Cole MA; Kalman BA; Spencer RL
J Steroid Biochem Mol Biol; 1998 Nov; 67(3):213-22. PubMed ID: 9879980
[TBL] [Abstract][Full Text] [Related]
4. The steroid receptor antagonists RU40555 and RU486 activate glucocorticoid receptor translocation and are not excreted by the steroid hormones transporter in L929 cells.
Pariante CM; Pearce BD; Pisell TL; Su C; Miller AH
J Endocrinol; 2001 May; 169(2):309-20. PubMed ID: 11312148
[TBL] [Abstract][Full Text] [Related]
5. Dose-dependent effects of corticosterone on nuclear glucocorticoid receptors and their binding to DNA in the brain and pituitary of the rat.
Spiga F; Lightman SL
Brain Res; 2009 Oct; 1293():101-7. PubMed ID: 19368803
[TBL] [Abstract][Full Text] [Related]
6. Differences between brain structures in nuclear translocation and DNA binding of the glucocorticoid receptor during stress and the circadian cycle.
Kitchener P; Di Blasi F; Borrelli E; Piazza PV
Eur J Neurosci; 2004 Apr; 19(7):1837-46. PubMed ID: 15078557
[TBL] [Abstract][Full Text] [Related]
7. Chronic brain glucocorticoid receptor blockade enhances the rise in circadian and stress-induced pituitary-adrenal activity.
van Haarst AD; Oitzl MS; Workel JO; de Kloet ER
Endocrinology; 1996 Nov; 137(11):4935-43. PubMed ID: 8895366
[TBL] [Abstract][Full Text] [Related]
8. Selective blockade of the mineralocorticoid receptor impairs hypothalamic-pituitary-adrenal axis expression of habituation.
Cole MA; Kalman BA; Pace TW; Topczewski F; Lowrey MJ; Spencer RL
J Neuroendocrinol; 2000 Oct; 12(10):1034-42. PubMed ID: 11012846
[TBL] [Abstract][Full Text] [Related]
9. Glucocorticoids decrease astrocyte numbers by reducing glucocorticoid receptor expression in vitro and in vivo.
Unemura K; Kume T; Kondo M; Maeda Y; Izumi Y; Akaike A
J Pharmacol Sci; 2012; 119(1):30-9. PubMed ID: 22641130
[TBL] [Abstract][Full Text] [Related]
10. Effects of selective and non-selective glucocorticoid receptor II antagonists on rapid-onset diabetes in young rats.
Beaudry JL; Dunford EC; Teich T; Zaharieva D; Hunt H; Belanoff JK; Riddell MC
PLoS One; 2014; 9(3):e91248. PubMed ID: 24642683
[TBL] [Abstract][Full Text] [Related]
11. The selective glucocorticoid receptor antagonist CORT125281 has tissue-specific activity.
Koorneef LL; Kroon J; Viho EMG; Wahl LF; Heckmans KML; van Dorst MMAR; Hoekstra M; Houtman R; Hunt H; Meijer OC
J Endocrinol; 2020 Jul; 246(1):79-92. PubMed ID: 32369774
[TBL] [Abstract][Full Text] [Related]
12. Effects of the glucocorticoid antagonist RU486 in spontaneously hypertensive and Sprague Dawley rats.
Soro A; Panarelli M; Holloway CD; Fraser R; Kenyon CJ
J Endocrinol Invest; 1995 Dec; 18(11):833-9. PubMed ID: 8778154
[TBL] [Abstract][Full Text] [Related]
13. Evidence for mineralocorticoid receptor facilitation of glucocorticoid receptor-dependent regulation of hypothalamic-pituitary-adrenal axis activity.
Spencer RL; Kim PJ; Kalman BA; Cole MA
Endocrinology; 1998 Jun; 139(6):2718-26. PubMed ID: 9607777
[TBL] [Abstract][Full Text] [Related]
14. Traumatic brain injury regulates adrenocorticosteroid receptor mRNA levels in rat hippocampus.
McCullers DL; Sullivan PG; Scheff SW; Herman JP
Brain Res; 2002 Aug; 947(1):41-9. PubMed ID: 12144851
[TBL] [Abstract][Full Text] [Related]
15. Activation of glucocorticoid receptors increases 5-HT2A receptor levels.
Trajkovska V; Kirkegaard L; Krey G; Marcussen AB; Thomsen MS; Chourbaji S; Brandwein C; Ridder S; Halldin C; Gass P; Knudsen GM; Aznar S
Exp Neurol; 2009 Jul; 218(1):83-91. PubMed ID: 19379741
[TBL] [Abstract][Full Text] [Related]
16. Mifepristone protects CA1 hippocampal neurons following traumatic brain injury in rat.
McCullers DL; Sullivan PG; Scheff SW; Herman JP
Neuroscience; 2002; 109(2):219-30. PubMed ID: 11801359
[TBL] [Abstract][Full Text] [Related]
17. (-)-nicotine ameliorates corticosterone's potentiation of N-methyl-d-aspartate receptor-mediated cornu ammonis 1 toxicity.
Mulholland PJ; Self RL; Harris BR; Littleton JM; Prendergast MA
Neuroscience; 2004; 125(3):671-82. PubMed ID: 15099681
[TBL] [Abstract][Full Text] [Related]
18. Restoration of neuroendocrine stress response by glucocorticoid receptor or GABA(A) receptor antagonists after experimental traumatic brain injury.
Taylor AN; Tio DL; Sutton RL
J Neurotrauma; 2013 Jul; 30(14):1250-6. PubMed ID: 23384619
[TBL] [Abstract][Full Text] [Related]
19. Chronic treatment with the glucocorticoid receptor antagonist RU486 inhibits diabetes-induced enhancement of experimental periodontitis.
Breivik T; Gundersen Y; Gjermo P; Opstad PK
J Periodontal Res; 2014 Feb; 49(1):36-44. PubMed ID: 23586673
[TBL] [Abstract][Full Text] [Related]
20. Limited brain diffusion of the glucocorticoid receptor agonist RU28362 following i.c.v. administration: implications for i.c.v. drug delivery and glucocorticoid negative feedback in the hypothalamic-pituitary-adrenal axis.
Francis AB; Pace TW; Ginsberg AB; Rubin BA; Spencer RL
Neuroscience; 2006 Sep; 141(3):1503-15. PubMed ID: 16806720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
